MedPath

Effect of warfarin and rivaroxaban in coronary endartherectomy

Phase 2
Recruiting
Conditions
Condition 1: Coronary arthry disease. Condition 2: .
Atherosclerotic heart disease
Registration Number
IRCT20181124041746N1
Lead Sponsor
Kermanshah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

Patients undergoing CABG and endarterectomy

Exclusion Criteria

Patients with prosthetic valve
ESRD patents

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath